Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study

BACKGROUND: Although initial therapy with a parenteral anticoagulant is required before edoxaban, this strategy is frequently avoided in actual clinical practice because of its complexity. This study assessed the feasibility of edoxaban without initial heparin usage for asymptomatic cancer-associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Michio, Ishiguro, Atsushi, Dazai, Masayoshi, Kawamoto, Yasuyuki, Yuki, Satoshi, Sogabe, Susumu, Hosokawa, Ayumu, Sawada, Kentaro, Muto, Osamu, Izawa, Naoki, Nakashima, Koji, Horie, Yoshiki, Yagisawa, Masataka, Kajiura, Shinya, Ando, Takayuki, Mitsuhashi, Yosuke, Sunakawa, Yu, Kikuchi, Yasuka, Komatsu, Yoshito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757916/
https://www.ncbi.nlm.nih.gov/pubmed/36526992
http://dx.doi.org/10.1186/s12885-022-10403-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757916/
https://www.ncbi.nlm.nih.gov/pubmed/36526992
http://dx.doi.org/10.1186/s12885-022-10403-y

Ejemplares similares